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Abstract
Background: Hypoxia-mediated HIF-1a stabilization and NF-kB activation play a key role in carcinogenesis by fostering
cancer cell survival, angiogenesis and tumor invasion. Gangliosides are integral components of biological membranes with
an increasingly recognized role as signaling intermediates. In particular, ganglioside GD3 has been characterized as a
proapoptotic lipid effector by promoting cell death signaling and suppression of survival pathways. Thus, our aim was to
analyze the role of GD3 in hypoxia susceptibility of hepatocarcinoma cells and in vivo tumor growth.
Methodology/Principal Findings: We generated and characterized a human hepatocarcinoma cell line stably expressing
GD3 synthase (Hep3B-GD3), which catalyzes the synthesis of GD3 from GM3. Despite increased GD3 levels (2–3 fold), no
significant changes in cell morphology or growth were observed in Hep3B-GD3 cells compared to wild type Hep3B cells
under normoxia. However, exposure of Hep3B-GD3 cells to hypoxia (2% O2) enhanced reactive oxygen species (ROS)
generation, resulting in decreased cell survival, with similar findings observed in Hep3B cells exposed to increasing doses of
exogenous GD3. In addition, hypoxia-induced c-Src phosphorylation at tyrosine residues, NF-kB activation and subsequent
expression of Mn-SOD were observed in Hep3B cells but not in Hep3B-GD3 cells. Moreover, MnTBAP, an antioxidant with
predominant SOD mimetic activity, reduced ROS generation, protecting Hep3B-GD3 cells from hypoxia-induced death.
Finally, lower tumor growth, higher cell death and reduced Mn-SOD expression were observed in Hep3B-GD3 compared to
Hep3B tumor xenografts.
Conclusion: These findings underscore a role for GD3 in hypoxia susceptibility by disabling the c-Src/NF-kB survival
pathway resulting in lower Mn-SOD expression, which may be of relevance in hepatocellular carcinoma therapy.
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Introduction
Hypoxia is a prominent characteristic of advanced solid tumors
and a major determinant of malignant progression and therapy
responsiveness [1–2]. Although, the molecular mechanisms
responsible for the cellular adaptation to hypoxia is still under
debate, with prolylhydroxylases playing a fundamental role [3],
mitochondrial reactive oxygen species (ROS) generation is
believed to contribute to this process, as hypoxia-induced
mitochondrial ROS has been shown to determine HIF-1a
stabilization and NF-kB activation [4–5].
Despite a key structural role in biological membranes, glyco-
sphingolipids (GSLs) are increasingly recognized as secondary
intermediates that participate in various cellular processes, including
cell adhesion, differentiation, signal transduction and cell death
[6,7]. In particular, ganglioside GD3 (GD3) has been identified as a
lipid death effector [8], with a dual mechanism involving its
interaction with mitochondria leading to activation of apoptotic
pathways [9,10] and the suppression of survival programs mediated
by NF-kB activation [11,12]. In addition, the acetylation of GD3 by
O-acetyl disialoganglioside synthase antagonizes its apoptotic
potential and has been shown to regulate tumor cell growth and
differentiation [13,14]. Thus, GD3 acetylation represents a novel
mechanism whereby specific tumor cells with elevated GD3 levels
escape from GD3-induced cell death [15].
We have recently shown that mitochondrial ROS play a dual role
in hypoxia signaling [5]. While hypoxia-induced ROS protected
cancer cells by NF-kB activation through a c-Src-dependent
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mechanism, ROS overproduction following mitochondrial GSH
depletion sensitized cancer cells to hypoxia. Given the role of
exogenous GD3 in chemotherapy susceptibility [16] and its ability
to disable survival pathways dependent on NF-kB activation
[11,12], the purpose of the present study was to examine the role
of GD3 in hypoxia susceptibility and in vivo tumor growth. To this
aim, we generated and characterized a human hepatocarcinoma
cell line stably transfected with GD3 synthase. Our results indicate
that overexpression of GD3 synthase increases the levels of GD3,
which is synthesized from endogenous GM3, rendering Hep3B cells
susceptible to hypoxia-induced ROS generation by suppressing the
hypoxia-mediated NF-kB activation via c-Src, which results in
lower expression of the kB-dependent antioxidant Mn-SOD.
Moreover, GD3 synthase overexpression reduces tumor growth in
vivo in Hep3B-GD3 xenografts. Thus, these findings identify GD3 as
a potential relevant therapeutic agent to switch hypoxia from a
cancer-promoting to a cancer-threatening environment.
Results
Stable Expression of GD3 Synthase in Hep3B Cells
Many tumors cells exhibit enhanced synthesis of selected
gangliosides and abnormalities in GSLs biosynthesis have been
implicated in the oncogenesis and malignancy of cancer cells,
particularly in neuroectodermal tumors (melanoma and neuro-
blastoma) [17]. However, the pattern of GSLs expression in
human hepatocarcinoma cells has been less explored, with reports
showing a low expression of endogenous GD3 in specific cell lines
[18,19]. In fact, while GM3 is the most abundant ganglioside in
human liver (around 90%) followed by GD3 (around 5%) [20], in
pathological conditions such as cirrhosis or HCC, changes in the
ganglioside pattern of GM3 and GD3 and the appearance of
minor species (e.g. GM2 or GD1a) are common features [21].
Given the dual role of GD3 in cell death regulation [8–11], our
aim was to examine the contribution of GD3 to hypoxia
susceptibility in human hepatocarcinoma cells following GD3
synthase overexpression. We first characterized the pattern of
endogenous GSLs in Hep3B cells, stably transfected with an empty
pcDNA vector, following incubation with [3H]-galactose and
subsequent TLC analysis (Figure 1A), and compared it with the
levels observed in Hep3B cells transfected with GD3 synthase full-
length cDNA (Hep3B-GD3). As expected from the overexpression
of GD3 synthase, the predominant changes in the GSLs profile of
Hep3B-GD3 cells included a decrease in the content of GM3
accompanied by a significant increase in GD3 levels, as expected
after GD3 synthase overexpression, without changes in other
Figure 1. Characterization of GD3 synthase-overexpressing Hep3B cells. A. Representative image of lipids extracts resolved by HPTLC from
Hep3B cells transfected with and empty vector (3B) or overexpressing GD3 Synthase (3B-GD3) isotopically labeled with 3H-galactose, and
quantification of three independent experiments. Commercial non-labeled standards were run in parallel, being TLC plates stained with 5% orcinol
solution. *p,0.05 vs. Hep3B control cells. B. GD3 synthase activity was measured in control Hep3B (3B) and Hep3B GD3-expressing cells (3B-GD3).
GD3 Synthase protein levels were analyzed by western blot and compared with b-actin levels, used as a control. C. Confocal immunofluorescence was
visualized in empty-vector containing and GD3 Synthase overexpressing Hep3B cells using antibodies anti-GD3 and anti-Mn-SOD. The graphs on the
right panel represent the fluorescence intensity profile plotted from a to b direction in the merge images for the different cell lines (Mn-SOD in green
and GD3 in red). D. Cell growth under normoxic conditions (n = 3). *p,0.05 vs. Hep3B control cells.
doi:10.1371/journal.pone.0008059.g001
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glycosphingolipids. Consistent with these changes, we analyzed
both the expression of GD3 synthase by western blot and its
activity (Figure 1B). As seen, Hep3B-GD3 cells exhibited a
significant increased in either protein level and activity compared
to control Hep3B cells transfected with the empty vector. This
enhanced expression in GD3 synthase translated in increased GD3
levels (2–3 fold) and a subsequent decrease in endogenous GM3
content (Figure 1A). Moreover, although plasma membrane is a
predominant site for GSL, GD3 in particular has been located in
other subcellular organelles, including mitochondria in various cell
types [10,22–23]. Hence, we next analyzed by confocal immuno-
fluorescence if changes in the cell morphology or in the subcellular
distribution of GD3 were induced by the accumulation of GD3 in
Hep3B-GD3 cells, as previously measured by HPTLC
(Figure 1C). As seen, Hep3B-GD3 cells displayed enhanced
GD3 levels both at the cell surface and in internal membranes,
most likely including mitochondria, as revealed by the merged
fluorescence upon mitochondrial staining with antibody anti-Mn-
SOD (Figure 1C). Despite the increase in GD3 levels, however,
the morphology and growth rate of Hep3B-GD3 cells under
normoxia did not differ with respect to Hep3B cells (Figure 1D),
suggesting that the intracellular GD3 levels in Hep3B-GD3 cells
were insufficient to cause cell death or ROS generation. Indeed,
under these growing conditions we did not detect a significant
increase in ROS despite the presence of GD3 in mitochondria (not
shown). These findings indicate that stimulated GD3 levels
following GD3 synthase overexpression do not exert any obvious
effects in Hep3B-GD3 cells grown under normoxia. The lack of
endogenous ROS formation in Hep3B-GD3 cells under normoxia
is of interest given the potential trafficking of GD3 to
mitochondria, especially in light of the reported observations that
the targeting of GD3 to mitochondria results in ROS formation
[10,23]. Thus, although we did not examine the threshold for the
mitochondrial stimulation of ROS formation by GD3 in Hep3B-
GD3 cells, these data imply that the mitochondrial trafficking of
GD3 in the transfected cells may be insufficient to cause significant
ROS generation, consistent with the lack of effects on cell
morphology and growth. In support for this, increasing doses of
exogenous GD3 in Hep3B cells grown in normoxia caused cell
death (Figure 2A) and stimulated ROS generation (not shown), in
line with previous observations [9].
Hep3B-GD3 Cells Become Susceptible to Hypoxia-
Induced ROS
Hypoxia has been shown to stimulate ROS production [4,24]
whose impact on cell survival is controlled by NF-kB activation
[5]. Since GD3 has been shown to prevent NF-kB activation and
suppress kB-dependent gene expression [11,12,25], we next
analyzed the susceptibility of Hep3B-GD3 cells to hypoxia.
Interestingly, in contrast to the outcome observed in normoxia,
we observed a time-dependent decrease in the viability of Hep3B-
GD3 cells following hypoxia exposure (2% O2) compared to
Figure 2. GD3 ganglioside sensitizes Hep3B cells to hypoxia and potentiates ROS generation. A. Cell death in Hep3B cells growing under
normoxia or hypoxia for 48 h, and treated with increasing doses of GD3. Cell viability measured 24 h later (n = 3). B. Time-dependent viability of
Hep3B and Hep3B-GD3 cells exposed to 2% O2 (n = 3). C, D. ROS generation evaluated with fluorescent probes HE (5 mM) and DCF (1 mM) during
30 min at 37uC (n = 4). *p,0.05 vs. Hep3B cells. #p,0.05 vs. hypoxic Hep3B cells.
doi:10.1371/journal.pone.0008059.g002
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control Hep3B cells transfected with empty vector examined by
MTT (Figure 2B), LDH leakage (not shown) or flow cytometry
analysis of propidium iodide exclusion in non permeabilized cells
(Figure S1). Of note, all selected clones with enhanced GD3
overexpression (over 2 fold increase in activity) displayed similar
sensitivity to hypoxic culture with respect to control Hep3B cells
(data not shown). Moreover, there was no changes in cell cycle
distribution (Figure S2), and administration of a pan-caspase
inhibitor (qVD-OPH) did not rescue Hep3B-GD3 cells from
hypoxia-mediated cell death (Figure S3), suggesting that Hep3B-
GD3 cells die by necrosis when grown under hypoxia. We next
examined the effect of GD3 synthase downregulation in hypoxia
susceptibility. RNA interference against GD3 synthase through
transfection of specific siRNAs reduced the mRNA and protein
levels in Hep3B cells compared to Hep3B cells transfected with
scrambled control siRNA (Figure S4). However, this outcome did
not change the viability of Hep3B cells neither under normoxic
nor hypoxic conditions (102.1%63.8 and 96.6%65.5 respective-
ly, examined by MTT, compared to Hep3B cells transfected with
control siRNA, 97.5%65.4 and 95.7%64.9, respectively),
although the siRNA against GD3 synthase reversed the suscep-
tibility of Hep3B-GD3 cells to hypoxia. Indeed, the downregula-
tion of GD3 synthase in Hep3B-GD3 cells conferred hypoxia
resistance similar to Hep3B cells (viability of 86.6%66.9 vs.
60.8%64.5 in Hep3B-GD3 cells after 3 days under 2% O2
hypoxia). Coupled with the dose-dependent effect of exogenous
GD3 in normoxia (Figure 2A), this result indicates that the GD3
effect on cell death is not strictly concentration-dependent,
suggesting a threshold phenomenon with a critical GD3 level
above which stimulates hypoxia-mediated cell death.
Since hypoxia-mediated superoxide anion can be converted
mainly by Mn-SOD catalysis into hydrogen peroxide, we next
analyzed the levels of both species using HE and DCF staining,
respectively. As shown, both species increased under hypoxia in
control Hep3B cells transfected with empty vector, being the
magnitude of the generation significantly enhanced in Hep3B-
GD3 cells upon prolonged exposure to hypoxia (Figure 2C, D).
Although the time-dependent changes in cell viability and levels of
HE and DCF fluorescence suggest that hypoxia exceeds a critical
threshold of ROS generation that compromises cell viability in
Hep3B-GD3 cells, we cannot discard the generation of other
potentially toxic species such as peroxinitrate, which may also
contribute to DCF fluorescence.
To verify that the increase in GD3 contributed to the cell death
observed in hypoxic conditions, we examined the susceptibility of
Hep3B cells to the exogenous administration of GD3 during
hypoxia. As observed, GD3 potentiated the death of Hep3B cells
following hypoxia incubation, even at low doses at which GD3 had
no effect under normoxia (Figure 2A). However, higher
concentrations of GD3 killed Hep3B independently of the oxygen
levels, correlating with higher ROS formation (not shown). Similar
findings showing sensitization to hypoxia by exogeneous GD3
exposure were observed in other cancer cell types including
human neuroblastoma SH-SY5Y cells (Figure S5) or HepG2 cells
(not shown), indicating that the sensitizing effect of GD3 is not cell
specific. Thus, although other reports indicated that GD3 induces
ROS generation [9,25–27], our data indicating that GD3
amplified hypoxia-induced ROS formation and subsequent cell
death, do not support a direct role for GD3 in ROS generation in
Hep3B-GD3 cells based on the outcome observed in normoxia
(Figure 1D). Rather, we hypothesized that the potentiation of
ROS formation in Hep3B-GD3 cells by hypoxia may have been
the result of the interference of NF-kB-mediated antioxidant
expression (e.g. Mn-SOD) by GD3, consistent with previous
reports showing the ability of gangliosides to prevent NF-kB
activation in primary hepatocytes [10] or T cells [12,25], which is
specifically examined next.
GD3 Synthase Overexpression Prevents c-Src Activation
and Subsequent NF-kB Transactivation
As suggested in the preceding findings and since ROS
production during hypoxia has been shown to participate in
NF-kB activation [5], we next examined the effect of GD3
synthase overexpression in p65 nuclear levels. Compared with
the nuclear levels of c-Jun as control, p65 nuclear translocation
following hypoxia increased in Hep3B cells, and this event was
suppressed in Hep3B-GD3 cells (Figure 3A). Of note,
hypoxia-induced HIF-1a levels were comparable in Hep3B
and Hep3B-GD3 cells (Figure 3A), and consistent with this
outcome, no changes in the mRNA of HIF-dependent genes
(pyruvate dehydrogenase kinase 1, PDK1; and vascular
endothelial growth factor, VEGF) were detected (data not
shown), underscoring the specificity of the inhibition of NF-kB
activation by GD3. Moreover, using a reporter luciferase
vector with NF-kB consensus sequences in its promoter, we
next assessed the changes in transcriptional activity of NF-kB.
As observed, luciferase activity increased in Hep3B cells when
grown under hypoxia, and this response was significantly
attenuated in Hep3B-GD3 cells (Figure 3B), thus indicating
that GD3 impairs hypoxia-induced NF-kB-mediated gene
expression.
Hypoxia has been shown to activate NF-kB through IkB
tyrosine phosphorylation via c-Src [5]. Hence, we next checked
the status of c-Src in Hep3B-GD3 cells during hypoxia to examine
whether this pathway is also susceptible to GD3 inhibition. As
seen, the phosphorylation of c-Src in tyrosine 416 induced by
hypoxia was observed in Hep3B cells but, unexpectedly, it was
abrogated in Hep3B-GD3 cells (Figure 3C), suggesting that the
interference of GD3 with c-Src stimulation contributed to the
suppression of NF-kB activation elicited by hypoxia.
We next focused on the potential consequences of the
suppression of the cSrc/NF-kB pathway, specifically analyzing
the expression of Mn-SOD, a key antioxidant enzyme that
downregulates mitochondrial ROS, which is transcriptionally
controlled by NF-kB. As seen, Mn-SOD mRNA levels increased
in Hep3B cells following hypoxia, but this response was markedly
blunted in Hep3B-GD3 cells (Figure 3D). To evaluate if the
inhibitory action of GD3 on the cSrc/NF-kB pathway induced by
hypoxia was cell type specific or common to other hepatoma cells,
HepG2 cells were cultured under hypoxic conditions examining c-
Src tyrosine phosphorylation and Mn-SOD expression after GD3
administration. GD3 addition in the last 24 hours of hypoxia
exposure blocked the c-Src tyrosine phosphorylation induced by
72 hours of hypoxia (2% O2), abrogating the increase of Mn-SOD
levels observed in hypoxic cells (Figure S6). These results suggest
not only that the inhibitory effect of GD3 is not specific for a
particular hepatoma cell line, but also that exogenous GD3
antagonizes the c-Src/NF-kB pathway induce by hypoxia,
reproducing the effects observed with the stably expression of
GD3 synthase in Hep3B-GD3 cells, which minimizes the potential
contribution of artifacts during clone selection.
Finally, to evaluate whether Mn-SOD participates in the
elimination of the hypoxia-induced ROS production, GD3
synthase-overexpressing cells were incubated with MnTBAP, a
porphyrin derivative with antioxidant activities that acts predom-
inantly as a SOD mimetic. Interestingly, MnTBAP drastically
reduced the production of superoxide anion and hydrogen peroxide
examined by HE and DCF fluorescence, respectively, (Figure 3E),
GD3 Synthase and Liver Cancer
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and more importantly, MnTBAP significantly protected Hep3B-
GD3 cells from hypoxia-induced cell death (Figure 3F). The
findings showing a decrease in DCF fluorescence by MnTBAP are
interesting and somewhat unexpected, as the decrease in superoxide
anion by MnTBAP would be anticipated to result in increased DCF
fluorescence. However, we speculated that the fate of hydrogen
peroxide generated from the scavenging of superoxide anion is
governed by the content of mitochondrial GSH. To prove this
point, we examined in isolated rat liver mitochondria the levels of
superoxide anion and hydrogen peroxide induced by xanthine plus
xanthine oxidase (X+XO) with or without mitochondrial GSH
depletion upon ethacrinic acid (EA) pretreatment (Figure S7). As
seen, unlike MitoSox fluorescence, DCF fluorescence increased
significantly by MnTBAP only upon mitochondrial GSH depletion
by EA, indicating that the status of mitochondrial GSH controls the
fate of hydrogen peroxide produced by the scavenging of superoxide
anion. In line with these data in isolated rat liver mitochondria,
Hep3B and Hep3B-GD3 cells exhibited mitochondrial GSH levels
(4–5 nmol/mg protein) which are in the range of those observed in
freshly isolated rat liver mitochondria (Figure S7), suggesting that
the generation of hydrogen peroxide resulting from the scavenging
of superoxide anion by MnTBAP is efficiently reduced by an
adequate GSH redox system. Moreover, in agreement with
previous findings [5], we observed that p65 silencing abrogated
Mn-SOD expression during hypoxia resulting in decreased cell
viability of Hep3B cells, and that this effect was reversed by
MnTBAP. Thus, these findings lend further support for a
critical role for Mn-SOD in the susceptibility to hypoxia due to
GD3 synthase overexpression, and strongly suggest that GD3
accumulation prevents hypoxia-mediated NF-kB activation by
interfering with cSrc/NF-kB survival pathway that mediates
MnSOD expression.
GD3 Synthase Overexpression Reduces In Vivo Tumor
Growth
A growing body of evidence indicates that HIF-1a contributes
to tumor progression and metastasis both in human tumors [28]
and xenograph models [29]. In particular, subcutaneous tumors of
Hep3B cells in mouse have been demonstrated to grow under
hypoxic conditions, and have been used as a model to check
potential anticancer HIF-targeting drugs [30]. Moreover, subcu-
taneous implants of human cervical squamous carcinoma have
been validated to grow under hypoxia shown by pimonidazole
staining in tumor samples [31]. Nevertheless, we verified in the in
vivo model that tumor cells were growing in a hypoxic environment
by measuring the mRNA levels of well-known HIF-dependent
genes such as PDK1 or VEGF, which are controlled by a hypoxia
response element (HRE) in their promoters, as well as the HIF-1a
expression. As shown, Hep3B cells from subcutaneous tumors
displayed a significant increase in the mRNA levels of PDK1 and
VEGF compared to Hep3B cultured under normoxic conditions
(Figure 4A, B), and increased HIF-1a levels (Figure S8).
Therefore, we next addressed the relevance of the preceding in vitro
findings by examining their impact in in vivo tumor xenografts, in
which nude mice were inoculated subcutaneously with Hep3B
(with empty vector) or Hep3B-GD3 cells to examine the course of
tumor progression and Mn-SOD expression. Tumor volume,
determined by a vernier caliper as detailed before [32], increased
over time in mice injected subcutaneously with Hep3B cells, while
Figure 3. Overexpression of GD3 blocks NF-kB transcriptional activity and downregulates Mn-SOD expression in hypoxic cells. A.
Representative western blots of p65 and HIF-1a from nuclear extracts of control (3B) and GD3-overexpressing (3B-GD3) cells using c-jun and b-actin
as representative nuclear protein and cytosolic marker, respectively (n = 3). B, Luciferase activity in 3B and 3B-GD3 cells transfected with NF-kB
luciferase reporter construct (n = 4). C. Representative immunoblots with c-Src, phospho-Tyr416Src and Mn-SOD antibodies and normalized by b-actin
levels. D, Mn-SOD mRNA levels were analyzed by real-time PCR after 72 hours (n = 3). E, ROS production, and F, survival of Hep3B-GD3 in the presence
or absence of Mn-SOD mimetic, MnTBAP (50 mM) after 72 h hypoxia (n = 4). *p,0.05 vs. Hep3B cells. #p,0.05 vs. hypoxic control.
doi:10.1371/journal.pone.0008059.g003
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significantly smaller tumors derived from Hep3B-GD3 cells
(Figure 4C). In addition, we next examined the presence of
dying cells in the growing tumors by TUNEL staining. The
number of TUNEL positive cells was higher in tumors from
Hep3B-GD3-injected cells compared to those of Hep3B cells
(Figure 4D, E). Although TUNEL staining is indicative of
fragmented DNA from dying cells it does not discriminate between
necrosis or apoptosis. In addition, there was no difference in active
caspase-3-positive cells was found in tumor samples (data not
shown). Thus, in agreement with the in vitro findings, it appears
that necrosis is the predominant form of cell death in the in vivo
xenograpth model, although at present we cannot rule out the
participation of a mitochondrial apoptotic cascade. Moreover,
consistent with the suppression of NF-kB activation by hypoxia in
Figure 4. GD3 synthase overexpression decreases subcutaneous tumor growth of Hep3B cells. mRNA levels of PDK1 (A) and VEGF (B) in
Hep3B cells from subcutaneous tumors in nude mice or from cells growing under normal culture conditions with 21% O2 (n = 3–4). *p,0.05 vs.
normoxic Hep3B cells. C, Tumor volume was measured in nude mice injected with Hep3B (empty vector) and Hep3B-GD3 cells (n = 5–6 animals per
group). D, E. Representative TUNEL-staining in tumor samples from injected mice, and quantification of TUNEL-positive cells in each group as
indicated in methods (n = 3-4). *p,0.05 vs. Hep3B-injected mice. F. mRNA levels of Mn-SOD from Hep3B and Hep3B-GD3 subcutaneous tumors
(n = 4). *p,0.05 vs. Hep3B-injected mice.
doi:10.1371/journal.pone.0008059.g004
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the in vitro studies, the Mn-SOD mRNA levels were lower in tumor
biopsies from mice injected with Hep3B-GD3 cells compared to
those from Hep3B xenografts (Figure 4F). However, whether this
outcome is consequence of the defective c-Src/NF-kB signaling
induced by GD3 in the xenograph model, as observed above in
vitro, remains to be established. All together, these findings indicate
a correlation between reduced MnSOD expression and enhanced
cell death under hypoxia, which translates in impaired tumor
growth in Hep3B-GD3 xenografts.
Discussion
The present study examines the impact of increased GD3 levels
on hypoxia susceptibility in vitro and tumor growth in vivo. We
describe that the overexpression of GD3 synthase alters the
pattern of GSLs expression in human hepatocarcinoma cells, with
the most significant changes observed being the decrease in GM3
levels and the subsequent increase in GD3 stores. While this shift
does not result in changes in cell morphology or cell growth during
normoxia, it renders hepatocarcinoma Hep3B cells susceptible to
hypoxia-mediated ROS generation and subsequent cell death by
suppressing NF-kB-regulated Mn-SOD expression. Although most
of this sensitization can be attributable to GD3 overgeneration,
another potential contribution to this effect relates to the
accompanying downregulation of GM3 levels that is observed in
Hep3B-GD3. However, if this were the case one might expect that
lower GM3 levels would affect cell viability and growth rate in
normoxia, which was not the case; moreover, exogenous GM3
exposure did not reverse hypoxia susceptibility (not shown), thus
suggesting that the accompanying GM3 downregulation in
Hep3B-GD3 cells played a minor role in our observations. To
further support a causal role for GD3 accumulation in hypoxia
susceptibility in transfected cells, we observed that exogenous GD3
recapitulated the effects of hypoxia by inducing cell death and by
inhibiting the hypoxia-activated c-Src/NF-kB pathway. Although
this approach minimizes the potential contribution of artifacts
during clone selection, it has been shown that exogenous GD3 can
be modified to other sphingolipid species in the endocytic process,
even at the membrane location [33]. In particular, plasma
membrane-associated sialidases are expressed in the liver, which
by removing acid sialic residues may initiate ganglioside
catabolism. Consequently, less complex gangliosides and even
higher ceramide levels may be detected after exogenous
administration of gangliosides. Furthermore, an additional advan-
tage in using the GD3 synthase overexpression approach over the
exogenous addition of GD3 is that the former allowed us to
examine the in vivo relevance of intracellular GD3 accumulation in
tumor growth in xenografts.
In addition to the interference of NF-kB activation by GD3,
which has been observed in the past in various cell types
[11,12,16,25], a salient feature of the present study is the ability
of GD3 to disable the activation of c-Src induced by hypoxia, in
agreement with findings in epithelial cell adhesion and spreading,
in which GD3 blocked c-Src activation [34]. Due to the crucial
role of c-Src in NF-kB activation during hypoxia [5], the block of
c-Src activation emerges as a novel mechanism whereby GD3
inactivates NF-kB, although a direct effect on DNA-competent kB
members by GD3 shown previously [11,16] could contribute to
the final outcome of impaired kB-mediated gene expression and
subsequent attenuation of survival pathways (Figure 5). As the
nuclear localization sequence (NLS) of kB members is essential for
their nuclear translocation, we can postulate that GD3 may
interfere with this signal preventing their movement to the nuclei.
Whether GD3 directly interferes with a cluster of positive
aminoacids, part of the NLS involved in the nuclear translocation
of kB members, deserves further investigation. The mechanism
whereby GD3 prevents hypoxia-induced c-Src activation is
currently unknown. However, given the role of ROS in
hypoxia-mediated c-Src activation [5], our findings suggest the
involvement of a direct modulatory effect of GD3 on c-Src
independently of ROS generation. In this regard, it has been
previously found that gangliosides inhibit tyrosine phosphorylation
[35], particularly GD3, which has been shown to regulate the
activation of Lyn, a member of the Src family, by their interaction
in caveolae-like domains [36]. More recently it has been proposed
that GD3 participates in a multimolecular complex, composed of
sphingolipid-enriched membrane domains enriched in Src family
protein tyrosine kinases [37], and that alterations in the
composition of these domains affects c-Src activation. Whether a
similar mechanism is involved in our observations with Hep3B-
GD3 cells deserves further investigation.
Previous studies have shown that GD3 interacts with mito-
chondria, eliciting a burst of ROS generation [9,10,23,25].
Interestingly, although GD3 trafficked to intracellular compart-
ments in Hep3B-GD3 cells including mitochondria, the fact that
no significant ROS generation is observed during normoxia
suggests that that mitochondrial localization of GD3 upon GD3
synthase overexpression may seem insufficient to stimulate ROS
production in Hep3B-GD3. Our results, however, suggest that
mitochondria constitute the main source for the observed ROS
generation during hypoxia, consistent with previous findings
[4,5,24] and with the protection observed with MnTBAP, which
in the presence of GD3 results in the sensitization of Hep3B-GD3
cells. Thus, the combination of mitochondrial ROS generation
(induced by hypoxia) and the suppression of c-Src-mediated NF-
kB activation (by GD3) synergize to the sensitization of Hep3B-
GD3 to hypoxia (Figure 5). A caveat in the study relates to the
uncertainty in the mechanism of action of the SOD mimetic
MnTBAP. While its predominant function is as a SOD mimetic
scavenging superoxide anion, other reports indicated its potential
to scavenge peroxinitrate as well [38]. Regardless of its true
mechanism of action, the benefit of MnTBAP has been clearly
documented in Sod2tm1Cje null mice, in which MnTBAP
treatment prevented systemic pathology (dilated cardiomyopathy,
hepatic lipid accumulation), dramatically extending lifespan [39].
These data indicate that this antioxidant is able to functionally
replace Mn-SOD deficiency, suggesting that a predominant
mechanism in the protective effects of MnTBAP is via superoxide
anion elimination.
Our findings may be of therapeutic significance in vivo as
illustrated in hepatocarcinoma xenografts, in which tumor growth
and Mn-SOD expression were lower in Hep3B-GD3-derived
tumors. Whether or not it may be of potential relevance in the
clinical setting remains to be established, and experiments
analyzing the ganglioside profile in primary human liver tumors
in comparison with healthy liver biopsies may help to clarify this
important issue. Interestingly, Ruckha¨berle et al observed a worst
prognosis for breast cancer patients exhibiting tumors showing low
expression of GD3 synthase [40].
In conclusion, GD3 synthase overexpression in a human HCC
cell line catalyzes the conversion of endogenous GM3 stores into
GD3, which distributes to different cell sites. While GD3 increase
does not perturb cell growth/death during normoxia, it sensitizes
Hep3B cells to hypoxia-induced ROS generation, due to the
ability of GD3 to disable the cSrc/NF-kB pathway by an as yet
uncharacterized mechanism that translates in lower Mn-SOD
expression. Based on previous findings showing mitochondria as
the source of ROS during hypoxia [4,5,24], we speculate that
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mitochondria constitute the site of ROS overproduction in
Hep3B. In line with this possibility, MnTBAP, which has been
shown to be able to replace Mn-SOD deficiency in vivo, protected
Hep3B-GD3 cells from hypoxia-induced ROS overproduction.
Taken together, these findings mirrored the outcome observed in
Hep3B-GD3 xenografts, suggesting the potential relevance of
GD3 synthase overexpression in in vivo tumor growth and identify
GD3 as a potential relevant therapeutic agent to turn hypoxia into
a cancer-threatening milieu.
Materials and Methods
Cell Culture and Incubation
Human hepatocarcinoma Hep3B and HepG2 cells as well as
the human neuroblastoma SH-SY5Y cells were obtained from the
ECACC and cultured in a humidified incubator (RS Biotech) at
37uC and 5% CO2 either at 21% O2 (normoxia) or 2% O2
(hypoxia) in sealed flasks for 24–72 hours as previously described
[5,40]. Hypoxia was achieved in the incubator by displacing O2
Figure 5. Schematic diagram depicting the mechanism proposed to be involved in the susceptibility of Hep3B cells to hypoxia
upon GD3 synthase overexpression. In Hep3B cells, NF-kB activation via cSrc plays a key role in the resistance to hypoxia, in part, by inducing
Mn-SOD expression. However, in Hep3B-GD3 cells the overgeneration of GD3 blocks the cSrc/NF-kB pathway potentiating the mitochondrial ROS
production during hypoxia and contributing to hypoxia-mediated cell death.
doi:10.1371/journal.pone.0008059.g005
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with injected N2 using an Active Oxygen Control that allow to
maintain the O2 environment between 1% and 19% with a 0.1%
accuracy. In some cases, Hep3B and Hep3B-GD3 cells were
incubated in the presence of MnTBAP (50 mM), pan-caspase
inhibitor qVD-OPH (20 mM) or GD3 ganglioside (0–50 mM, stock
solution of 10 mM in ethanol) for the last 24 h of hypoxia to
examine their role in hypoxia susceptibility. The addition of
solvent alone used to dissolve GD3 to Hep3B did not affect cell
viability in normoxia or hypoxia (not shown).
Glycosphingolipids TLCs and GD3 Synthase Enzyme
Activity Assay
Cells (2–36106) were harvested by scraping and resuspended
in 50 ml of 10 mM sodium cacodylate buffer (pH 7.0). Samples
were subjected to lysis with an equal volume of 0.6% Triton
CF-54 in 50 mM sodium cacodylate buffer and 20 mM MgCl2
(assay buffer) during 20 min at 4uC and centrifuged for 10 min
at 14000 g. Supernatants (50 ml/activity assay) were supple-
mented with 15 ml of 2 mM GM3, 15 ml of 70 mM CMP-[14C]
sialic acid (0.3 mCi) and 20 ml of assay buffer and incubated for
3 h at 37uC. Blanks assays were performed with the heat-
inactivated enzyme. Radiolabelled glycolipids were separated
by Sephadex G-50 gel filtration and divided into two
equivalents portions: the first one was dried and counted in a
scintillation spectrometer and the remaining portion was
subjected to TLC. In addition, for the measurement of
glycosphingolipid intracellular levels, cells were isotopically
labeled with 3H-galactose 1 mCi/ml for 24 hours before lipid
extraction and TLC analyses. Samples were run in parallel
with commercial standards (Matreya) and TLC plates devel-
oped after spraying with 0.1% orcinol dissolved in 5% H2SO4,
and heated at 120uC for approximately 10 minutes.
Plasmid Construction and Cell Transfection
Full-length cDNA of GD3 synthase (Accession Number:
NM_003034) was obtained from the human glioblastoma cell
line U373 with the SuperScript preamplification Kit (Invitro-
gen) by PCR using the primers: forward 59-CACCATGAG-
CCCCTGCGGGCGG-39 and reverse 59- GGAAGTGGGC-
TGGAGTGAGGTATC-39. The PCR product (1.07 kb) was
cloned into pcDNA 3.1D/v5-His-TOPO with the directional
TOPO expression kit (Invitrogen) and verified by DNA sequencing.
Hep3B were transfected using Lipofectamine 2000 (Invitrogen)
with the full-length construct (Hep3B-GD3) or with the empty
vector (Hep3B). 23 different colonies overeexpressing GD3
synthase were selected based on their resistance to 1 mg/ml
G418 (Roche) during 4 weeks, while a pool of Hep3B cells
trasfected with the empty vector were used as control in all the
experiments. The GD3 synthase-expressing colony with higher
enzymatic activity was chosen, although other colonies with similar
activity were also tested, obtaining similar results in terms of
hypoxia susceptibility and c-Src/NF-kB regulation.
Measurement of ROS and Cytotoxicity
Hydroethidine (HE) (ex 495/em 610) and 29-79-dihydro
dichlorofluorescein diacetate (DCF) (ex 495/em 525) were from
Molecular Probes. Fluorescence was determined at 37uC and data
normalized with values from normoxic untreated controls [5].
Cytotoxicity was determined by MTT assay or through the
leakage of lactate dehydrogenase (LDH) into the medium. In
addition, cell viability was measured by exclusion of propidium
iodide (15 mg/ml; Sigma) after flow citometry analysis of non-
permeabilized cells.
Cell-Cycle Analysis
After 48–72 hours of hypoxic treatment, cells were fixed and
permeabilized in 100% ethanol, washed with PBS and stained
with propidium iodide (15 mg/ml) in the presence of 0.3 mg/ml
Ribonuclease A (Sigma). Cell-cycle distribution was assayed using
a BD FACSCalibur flow cytometer (Becton Dickinson).
Real-Time RT-PCR
Briefly, 20 ng of total RNA, 600 mmol/l of primers, and 12.5 ml
of 2X Reaction Mix (Sensimix One-Step, Quantance) were
incubated in 25 ml at 50uC for 10 min and 95uC for 5 min,
followed by 45 cycles of 95uC for 10 s, 56uC for 30 s, and 72uC for
30 s. Each reaction was run in duplicate and the threshold (CT)
values for Mn-SOD mRNA (BC012423), PDK1 (NM_002610.3)
or VEGF (NM_001025366.1|) were subtracted from that of b-
actin mRNA (NM_001101), averaged and converted from log-
linear to linear term. The primer sequences used were:
b-actin forward 59-TTGCCGACAGGATGCAGAA-39,
b-actin reverse 59-GCCGATCCACACGGAGTACT-39,
Mn-SOD forward 59- CCACCACCATTGAACTTCAG-39,
Mn-SOD reverse 59-GGCTGAGGTTTGTCCAGAAA-39.
PDK1 forward 59-GAAGCAGTTCCTGGACTTCG-39,
PDK1 reverse 59-ACCAATTGAACGGATGGTGT-39;
VEGF forward 59-CTACCTCCACCATGCCAAGTG-39,
VEGF reverse 59-TGCGCTGATAGACATCCATGA-39.
Cell Transfection with Reporter Construct and siRNA
Silencing
Briefly, 56105 were plated onto a 24 wells culture plates and
transiently transfected using LipofectamineTM 2000 (Invitrogen,
Carlsbad, CA) with the reporter plasmid pNF-kB-Luc and phRL-TK
for normalization. Cells were harvested 48–72 h after transfection,
and the Firefly and Renilla luciferase activities were measured with
the dual luciferase assay system according to the manufacturer’s
instructions (Promega). GD3 synthase RNA silencing was achieved in
Hep3B cells with target- specific siRNA duplexes (Santa Cruz) using
LipofectamineTM 2000 as transfecting agent and its related scramble
siRNA as a control. Protein and mRNA levels from siRNA-
transfected cells were analyzed after 48 hours of transfection, while
cell growth was determined during 72 hours.
Immunofluorescence
Cells grown in coverslips were rinsed with PBS, fixed and
permeabilized in acetone at -20uC for 10 min. After incubation
with PBS containing 5% BSA for 1 hour, monoclonal anti-GD3
antibody R24 (Calbiochem, 1:150 in PBS-BSA) was added at 4uC
overnight. In some instances, cells were labeled in parallel with
anti-Mn-SOD antibody to examine the colocalization of GD3
with mitochondria. Coverslips were washed with PBS, incubated
with Alexa Fluor 488 anti-mouse (Molecular Probes, 1:500, 1 h,
RT), and mounted in DakoCytomation fluorescent mounting
medium. Confocal images were collected using a Leica SP2 laser
scanning confocal microscope equipped with UV excitation, an
argon laser, a 633/1.32 OIL PH 3 CS objective and a confocal
pinhole set at 1 Airy unit. All the confocal images shown were
single optical sections.
Western Blotting
Blots were incubated with anti-P-Tyr 416 Src antibody (Cell
Signaling), anti-c-Src, anti-MnSOD2, anti-GD3 Synthase anti-
bodies (Santa Cruz) and anti-b-actin antibody (Sigma). Nuclear
extracts, obtained as described [5], were immunoblotted with anti-
GD3 Synthase and Liver Cancer
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p65, c-jun antibodies (Santa Cruz) and anti-HIF-1a (Novus
Biologicals).
Hepatocarcinoma Xenograft Model
All procedures were performed according to protocols approved
by the IDIBAPS Ethical Committee.
Six-week-old male BALB/c athymic (nu/nu) nude mice,
kept under pathogen-free conditions and given free access to
food and sterilized water, were s.c. injected with control
Hep3B or GD3-expressing (Hep3B-GD3) cells (2.56106 cells
in 200 mL of PBS) examining tumor growth with a vernier
caliper, as described previously [27]. After 8 weeks, samples
were taken for mRNA and TUNEL analysis using the In Situ
Cell Death Detection kit (Roche) as previously described [42].
Quantification was performed in 10 random-selected fields per
tumor with at least 200 cells/field each. mRNA from Hep3B
cells growing subcutaneously during 8 weeks in nude nice, and
from Hep3B cells cultured under normal conditions (21% O2,
5% CO2) were extracted simultaneously and the mRNA
expression of HIF-dependent genes (PDK1 and VEGF)
analyzed to verify the existence of hypoxic conditions in our
tumor samples.
Rat Liver Mitochondria Isolation, GSH Depletion and ROS
Generation
In order to address the role of GSH in the generation of
hydrogen peroxide from the scavenging of superoxide anion by
MnTBAP, rat liver mitochondria, isolated as previously described
[9,32], were incubated with xanthine plus xanthine oxidase
(0.1 mM plus 20 U/ml), as detailed previously [43], with or
without ethacrinic acid (0.5 mM) to deplete GSH levels.
Mitochondria were then incubated with or without MnTBAP
and the generation of superoxide anion and hydrogen peroxide
were determined [43].
Statistics
Results were expressed as mean 6 SD. Statistical significance of
the mean values was established by the two-tailed distribution
Student’s t test.
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